BCR-ABL fails to inhibit apoptosis in U937 myelomonocytic cells expressing a carboxyl-terminal truncated Stat5

被引:5
作者
Ahmed, M [1 ]
Dusanter-Fourt, I [1 ]
Dugray, A [1 ]
Dubrez, L [1 ]
Novault, S [1 ]
Bonnet, ML [1 ]
Gisselbrecht, S [1 ]
Varet, B [1 ]
Solary, E [1 ]
Vainchenker, W [1 ]
Turhan, AG [1 ]
机构
[1] Inst Gustave Roussy, INSERM, U362, F-94805 Villejuif, France
关键词
BCR-ABL; inhibition of apoptosis; U937; Cells; carboxyl-terminal truncated STATS; myelomonocytic cells;
D O I
10.3109/10428190109064601
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recent experimental data suggest that one of the major effects of BCR-ABL gene expression in hematopoietic cells is the inhibition of apoptosis. Although the exact mechanisms of this phenomenon are not clear, it is thought to be related to the fact that BCR-ABL induces several signalling pathways also activated by growth factors. In order to determine the anti-apoptotic role of BCR-ABL in a hematopoietic cell line and to by-pass the influence of cytokine-dependence, BCR-ABL gene was expressed in the autonomously growing myelomonocytic U937 cell line using retroviral vectors. There was no resistance to apoptosis induced by either serum deprivation or different doses of etoposide in any U937 clones expressing BCR-ABL protein. In addition to serum deprivation and etoposide, BCR-ABL-expressing clones were not protected from apoptosis induced by TNF, ceramide-C2 and FAS-cross-linking. BCL2 expression was absent in U937 cells and BAX levels were identical between Neo and BCR-ABL clones. To further investigate the mechanisms of this phenomenon, band-shift assays were performed to detect activation of STAT molecules. No constitutive activation of STATs was detected in either NeoR or BCR-ABL-U937 cells, although both IFN-gamma and GM-CSF activated STAT1 and STAT5, respectively, with similar kinetics in both NeoR and BCR-ABL-U937 cells. In addition, the GM-CSF-induced-STAT5 activation was found to be weakened in all clones expressing BCR-A-BL. In both control NeoR and BCR-ABL-transfected clones, band-shift assays revealed the presence of an abnormal truncated STAT5 recognized only by an anti- N-terminal but not by an anti-C-Terminal STAT5 antibody. These findings suggest a possible link between the absence of anti-apoptotic potential of BCR-ABL and abnormalities of the STAT5 pathway, including, absence of constitutive activation of STAT5, inhibition of GM-CSF-induced STAT5 activation and expression of a carboxyl-terminal-truncated STAT5.
引用
收藏
页码:445 / 455
页数:11
相关论文
共 46 条
[1]   BCR-ABL and constitutively active erythropoietin receptor (cEpoR) activate distinct mechanisms for growth factor-independence and inhibition of apoptosis in Ba/F3 cell line [J].
Ahmed, M ;
Dusanter-Fourt, I ;
Bernard, M ;
Mayeux, P ;
Hawley, RG ;
Bennardo, T ;
Novault, S ;
Bonnet, ML ;
Gisselbrecht, S ;
Varet, B ;
Turhan, AG .
ONCOGENE, 1998, 16 (04) :489-496
[2]   Primary proliferating immature myeloid cells from CML patients are not resistant to induction of apoptosis by DNA damage and growth factor withdrawal [J].
Albrecht, T ;
Schwab, R ;
Henkes, M ;
Peschel, C ;
Huber, C ;
Aulitzky, WE .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (03) :501-507
[3]   Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3 [J].
Amarante-Mendes, GP ;
Kim, CN ;
Liu, L ;
Huang, Y ;
Perkins, CL ;
Green, DR ;
Bhalla, K .
BLOOD, 1998, 91 (05) :1700-1705
[4]   APOPTOSIS IN CHRONIC MYELOID-LEUKEMIA - NORMAL RESPONSES BY PROGENITOR CELLS TO GROWTH-FACTOR DEPRIVATION, X-IRRADIATION AND GLUCOCORTICOIDS [J].
AMOS, TAS ;
LEWIS, JL ;
GRAND, FH ;
GOODING, RP ;
GOLDMAN, JM ;
GORDON, MY .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (02) :387-393
[5]   Functionally distinct isoforms of STAT5 are generated by protein processing [J].
Azam, M ;
Lee, C ;
Strehlow, I ;
Schindler, C .
IMMUNITY, 1997, 6 (06) :691-701
[6]   Heteromerization of the γc chain with the interleukin-9 receptor α subunit leads to STAT activation and prevention of apoptosis [J].
Bauer, JH ;
Liu, KD ;
You, Y ;
Lai, SY ;
Goldsmith, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :9255-9260
[7]  
BEDI A, 1994, BLOOD, V83, P2038
[8]  
BIERNAUX C, 1995, BLOOD, V86, P3118
[9]   The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease [J].
Bose, S ;
Deininger, M ;
Gora-Tybor, J ;
Goldman, JM ;
Melo, JV .
BLOOD, 1998, 92 (09) :3362-3367
[10]   Positive selection of apoptosis-resistant cells correlates with activation of dominant-negative STAT5 [J].
Bovolenta, C ;
Testolin, L ;
Benussi, L ;
Lievens, PMJ ;
Liboi, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) :20779-20784